MedPath

Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
Radiation: radiation therapy
Drug: chemotherapy
Registration Number
NCT00074152
Lead Sponsor
ETOP IBCSG Partners Foundation
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether chemotherapy is effective in treating women who have undergone surgery and radiation therapy for relapsed breast cancer.

PURPOSE: Randomized phase III trial to determine the effectiveness of adjuvant chemotherapy in treating women who have undergone resection for local and/or regional relapsed breast cancer.

Detailed Description

OBJECTIVES:

Primary

* Determine the efficacy of adjuvant chemotherapy, in terms of disease-free survival, in women with radically resected loco-regional relapsed breast cancer.

Secondary

* Determine the systemic disease-free and overall survival of patients treated with this regimen.

* Determine the sites of recurrence, incidence of second (non-breast) malignancies, and causes of death without relapse of breast cancer in patients treated with this regimen.

* Determine the quality of life of patients treated with this regimen (QOL portion closed 11/13/08).

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to prior chemotherapy (yes vs no), estrogen receptor (ER) positive and/or progesterone receptor (PR) positive (yes vs no), and location of recurrence (breast vs mastectomy scar/chest wall vs regional lymph nodes). Patients are randomized to 1 of 2 treatment arms.

* Arm I: Patients receive radiotherapy\* within 6 months after surgery.

* Arm II: Within 10 weeks after surgery, patients receive at least 3 courses of an adjuvant chemotherapy regimen as determined by the investigator. Patients also receive radiotherapy\* within 6 months after surgery and after the completion of chemotherapy OR integrated with chemotherapy.

NOTE: \*Patients with clear margins (R0) who received prior adjuvant radiotherapy are not required to receive further radiotherapy

Patients with ER and/or PR positive tumors also receive standard hormonal therapy.

Quality of life is assessed at baseline and at 9 and 12 months (QOL portion closed 11/13/08).

Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.

PROJECTED ACCRUAL: A total of 265 patients will be accrued for this study within 4 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
162
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm Iradiation therapyPatients receive radiotherapy\* within 6 months after surgery.
Arm IIchemotherapyWithin 10 weeks after surgery, patients receive at least 3 courses of an adjuvant chemotherapy regimen as determined by the investigator. Patients may receive radiotherapy within 6 months after surgery and after the completion of chemotherapy OR integrated with chemotherapy.
Primary Outcome Measures
NameTimeMethod
Disease-free Survival5 years after randomization
Secondary Outcome Measures
NameTimeMethod
Overall Survival5 years after randomization
Sites of First Failures5 years after randomization

Tumor recurrence in the breast, lymph nodes or other areas of the body including bone, lung, liver, central nervous system, bone marrow

Trial Locations

Locations (198)

Kaiser Permanente - Deer Valley

🇺🇸

Antioch, California, United States

Kaiser Permanente - Fremont

🇺🇸

Fremont, California, United States

Kaiser Permanente Medical Center - Hayward

🇺🇸

Hayward, California, United States

Kaiser Permanente Medical Center - Oakland

🇺🇸

Oakland, California, United States

Kaiser Permanente Medical Center - Redwood City

🇺🇸

Redwood City, California, United States

Kaiser Permanente Medical Center - Richmond

🇺🇸

Richmond, California, United States

Kaiser Permanente Medical Center - Roseville

🇺🇸

Roseville, California, United States

South Sacramento Kaiser-Permanente Medical Center

🇺🇸

Sacramento, California, United States

Kaiser Permanente Medical Center - Sacramento

🇺🇸

Sacramento, California, United States

Kaiser Permanente Medical Center - San Francisco Geary Campus

🇺🇸

San Francisco, California, United States

Scroll for more (188 remaining)
Kaiser Permanente - Deer Valley
🇺🇸Antioch, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.